Increased levels of urinary basic fibroblast growth factor in bladder cancer patients

Oncology Reports

Volumn 4, Issue 3, 1997, Pages 619-622

  Puricelli, Lydia ^a   De Lorenzo, Mariana ^a   Eijan, Ana Maria ^a   Malagrino, Hector ^a   Kes, Segismundo ^a   Pasik, Leonardo ^a   Matos, Elena ^a   De Kier Joffé, Elisa Bal ^a   Casabé, Alberto ^a  

^a Instituto de Oncologia Angel H Roffo   (Argentina)

Author keywords

angiogenic factors; bFGF; bladder cancer; tumor markers

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER EPIDEMIOLOGY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; URINE LEVEL;

EID: 0030914018     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.4.3.619     Document Type: Article

References (21)

1. Liu BC-S and Liotta LA: Biochemistry of bladder cancer and metastasis. Adv Bladder Cancer 19: 621-627, 1992.
2. Raghavan D, Shipley WU and Garnick MB: Biology and management of bladder cancer. N Engl J Med 322: 1129-1138, 1990.
3. Nguyen M, Watanabe H, Budson AE, Richie JP and Folkman J: Elevated levels of the angiogenic peptide basic fibroblast growih factor in urine of bladder cancer patients. J Natl Cancer Inst 85: 241-242, 1993.
4. Auerbach W and Auerbach R: Angiogenesis inhibition: a review. Pharmacol Theor 63: 365-311, 1994.
5. Basilico C and Moscatelli D: The FGF family of growth factors and oncogenes. Adv Cancer Res 59: 115-165, 1992.
6. Vlodavsky I, Bar-Shavit R, Ishai-Michaeli R, Bashkin P and Fuks Z: Extracellular sequestration and release of fibroblast growth factor: a regulatory mechanism? TIBS 16: 268-271, 1991.
7. Chodak GW, Scheiner CJ and Zetter BR: Urine from patients with transitional cell carcinoma stimulates migration of capillary endothelial cells. N Eng J Med 305: 869-874, 1981.
8. Chodak GW, Hospelhom V, Judge SM, Mayforth R, Kocppen H and Sasse J: Increased levels of fibroblast growth factor-like activity in urine from patients with bladder or kidney cancer. Cancer Res 48: 2083-2088, 1988.
9. Nguyen M, Watanabe H, Budson AE, Richie JP, Hayes DF and Folkman J: Elevated levels of an angiogenic peptide, basic fibroblast growth factor in the urine of patients with a wide spectrum of cancers. J Natl Cancer Inst 86: 356-361, 1994.
10. O'Brien TS, Smith K, Cranston D, Fuggle S, Bicknell R and Harris AL: Urinary basic fibroblast growth factor in patients with bladder cancer and benign prostatic hypertrophy. Brit J Urol 76: 311-314, 1995.
11. Fletcher RH, Fletcher SW and Wagner EH: Clinical Epidemiology. The essentials. Second edition. Fletcher RH, et al (eds). Williams and Wilkins, Baltimore, 1988.
12. Lin RY, Argenta PA, Sullivan KM and Adzick NS: Diagnostic and prognosis role of basic fibroblast growth factor in Wilm's tumor patients. Clin Cancer Res 1: 327-331, 1995.
13. Soutter A, Nguyen M, Watanabe H and Folkman J: Basic fibroblast growth factor secreted by an animal tumor is detectable in urine. Cancer Res 53: 5297-5299, 1993.
14. Allen LE and Maher PA: Expression of basic fibroblast growth factor and its receptor in an invasive bladder cancer cell line. J Cell Physiol 155: 368-372, 1993.
15. Palcy S, Chopin DK, Caruelle D, Ravery V, Barritault D and Caruelle JP: Fibroblast growth factors and their specific binding sites in normal urothelium and transitional cell carcinoma (TCC) of the human bladder. Cell Mol Biol 41: 565-575, 1995.
16. Gagandeep SP, Green B, Galzie Z, Poston GJ, Sutton R, Taylor BA and Kinsella AR: Expression of basic fibroblast growth factor in colorectal carcinoma. Int J Oncol 8: 191-195, 1996.
17. New BA and Yeoman L: Identification of basic fibroblast growth factor sensitivity and receptor and ligand expression in human colon tumor cell lines. J Cell Physiol 150: 320-326, 1992.
18. Wellstein A: Why monitor angiogenic factors in patient's urine. J Natl Cancer Inst 86: 328-329, 1994.
19. Fujimoto K, Ichimori Y, Kakizoe T, Okajima E, Sakamoto H, Sugimura T and Terada M: Increased serum levels of basic fibroblast growth factor in patients with renal cell carcinoma. Biochem Biophys Res Commun 180: 386-392, 1991.
20. Duensing S, Grosse J and Atzpodien J: Increased serum levels of basic fibroblast growth factor (bFGF) are associated with progressive lung metastasis in advanced renal cell cancer patients. Anticancer Res 15: 2331-2334, 1995.
21. Takei Y, Kurobe M, Uchida A and Hayashi K: Presence of high molecular weight basic fibroblast growth factor-like immunoreactive substances in sera of patients with breast cancer. J Clin Biochem Nutr 15: 57-64, 1993.